BachirSakrMD

Obstetrics & Gynecology • Providence, RI

Gynecologic Oncology

Physician

Join to view full profile

Dr. Sakr is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Sakr's full profile

Already have an account?

Office
101 Dudley st
Providence, RI 02905
Phone+1 401-453-7540

Fax+1 401-453-7785
Is this information wrong?

Education & Training

UPMC Medical EducationFellowship, Hematology and Medical Oncology, 1999 - 2002
Wayne State University School of MedicineResidency, Internal Medicine, 1996 - 1999
Lebanese University School of MedicineClass of 1995

Certifications & Licensure

MA State Medical License 2007 - 2024
RI State Medical License 2002 - 2024
PA State Medical License 2000 - 2002
MI State Medical License 1996 - 1999
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse Start of enrollment: 2007 Nov 01
Terminated
Phase 2
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer Start of enrollment: 2012 Apr 01
Terminated
Phase 2
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Start of enrollment: 2014 Jan 15
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study.
Mary L Lopresti, Jessica J Bian, Bachir J. Sakr, Rochelle Strenger, Robert D. Legare, Mary Anne Fenton, Sabrina M Witherby, Donald S Dizon, Sonali V Pandya, Ashley Stu...> ;Breast Cancer Research and Treatment. 2021 Jun 4
71 citations
Medical Marijuana Use in Oncology: A Review
Gianna Wilkie, Bachir J. Sakr, Tina Rizack> ;JAMA Oncology. 2016 May 1
7 citations
Advances in Medical Management of Early Stage and Advanced Breast Cancer: 2015
Sabrina M Witherby, Tina Rizack, Bachir J. Sakr, Robert D. Legare, William M. Sikov> ;Seminars in Radiation Oncology. 2016 Jan 1
16 citations
Adjuvant chemotherapy in T1a/bN0 HER2-positive or triple-negative breast cancers: application and outcomes.
Yazan Migdady, Bachir J. Sakr, William M. Sikov, Adam J. Olszewski> ;Breast. 2013 Oct 1
4 citations
Is tumor board relevant
Tina Rizack, Jennifer Gass, Robert D. Legare, Bachir J. Sakr, Don S. Dizon> ;The Breast Journal. 2013 May 1
19 citations
Effects of adjuvant chemotherapy in HER2-positive or triple-negative pT1ab breast cancers: a multi-institutional retrospective study.
Adam J. Olszewski, Yazan Migdady, Susan K. Boolbol, Paula Klein, K. Boachie-Adjei, Bachir J. Sakr, William M. Sikov, Theresa Shao> ;Breast Cancer Research and Treatment. 2013 Jan 26
Carboplatin (Cb), weekly nanoparticle, albumin-bound paclitaxel (wAb), and bevacizumab (Av) neoadjuvant chemotherapy (NAC) in HER2-negative breast cancer (BrCA): A BrU...
Sinclair N, Abu-Khalaf MM, Sakr BJ, Rizack T, Lannin DR, Gass JS, Strenger R, Bossuyt V, Fenton MA, Harris L, Sikov WM> ;J. Clin. Oncol.. 2011-05-20
4 citations
Breast cancer: adjuvant modalities.
Bachir J. Sakr, Don S. Dizon> ;Clinical Obstetrics and Gynecology. 2011 Mar 1
32 citations
Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women's cancer program.
Lindsay M. Kuroki, Ashley Stuckey, Priya Hirway, Christina Raker, Christina A. Bandera, Paul DiSilvestro, Cornelius O. Granai, Robert D. Legare, Bachir J. Sakr, Don S....> ;Gynecologic Oncology. 2010 Mar 1
Join now to see all

Hospital Affiliations

Rhode Island HospitalProvidence, Rhode Island
Women & Infants Hospital of Rhode IslandProvidence, Rhode Island
Kent HospitalWarwick, Rhode Island

BachirSakrMD

Dr. Sakr is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.